|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Series A Cumulative Convertible Preferred Stock | $ 3 | 02/04/2008 | P | 2.50 | (5) | (5) | Common stock | 8,333 | $ 10,000 | 33,333 | D | ||||
Common stock purchase warrants | $ 3.50 | 02/04/2008 | P | 4,167 | 02/04/2008 | 02/04/2014 | Common stock | 4,167 | (6) | 37,500 | D | ||||
Stock option (right to buy) | $ 2.90 | 05/21/2008 | A | 6,000 | 11/21/2008 | 05/21/2018 | Common stock | 6,000 | $ 2.90 | 43,500 | D | ||||
Stock option (right to buy) | $ 1.38 | 05/27/2009 | A | 25,000 | 05/27/2009(7) | 05/27/2019 | Common stock | 25,000 | $ 1.38 | 68,500 | D | ||||
Stock option (right to buy) | $ 1.38 | 05/27/2009 | A | 20,000 | 05/27/2009(7) | 05/27/2019 | Common stock | 20,000 | $ 1.38 | 88,500 | D |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
LUCI DAVID P |
X |
David P. Luci (by Stephen B. Thompson) | 11/02/2009 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | Dividend shares on Series A Cumulative Convertible Preferred Stock |
(2) | Shares issued per the Release Agreement between Mr. Luci and Access Pharmaceuticals regarding its acquisition of MacroChem Corporation and Mr. Luci's employment agreement with MacroChem Corporation |
(3) | Shares issued for exchange of MacroChem shares for Access Pharmaceuticals shares due to Access Pharmaceuticals acquisition of MacroChem Corporation |
(4) | Shares granted per consulting agreement. 66,667 vest immediately; 66,666 vest on 01/01/2010; and 66,666 vest on 06/01/2010. |
(5) | These securities are exercisable at any time and have no expiration date. |
(6) | These warrants were issued as additional consideration for the purchase of the Series A Cumulative Convertible Preferred Stock. |
(7) | 50% vest immediately; 50% vest on 11/27/2009. |